March 2024 drug trend report
March 13, 2024
Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview and connect with your local pharmacy team to learn more.
Brand name drug launches*
Uzedy™
- Indicated for: Treatment of schizophrenia in adults
- Dosage form: Long-acting injectable administered subcutaneously in the abdomen or upper arm.
- Status: Available now
For more information on the new treatment option for adults living with schizophrenia, read the Uzedy™ blog post here.
Generic drug launches*
Pradaxa (dabigatran etexilate mesylate)
- Indicated for: Treatment of nonvalvular partial fibrillation and venous thromboembolism
- Dosage form: Capsules
- Status: Available now
Top drug shortages*
Naltrexone
- Indicated for: Treatment of alcohol and/or opioid use disorder
- Status: Recovery TBD
Trulicity
- Indicated for: Treatment of type 2 diabetes
- Status: Recovery TBD
Paliperidone
- Indicated for: Treatment of schizophrenia and schizoaffective disorder
- Status: Recovery TBD
People-first, full-service pharmacy
Stay connected!
For regular updates on drug trends, shortages, and other behavioral health news, subscribe to Genoa’s newsletter and sign up for event and insights notifications. Looking for more information on Genoa and our pharmacy services? Contact us and we’ll be in touch.
*Information on this page was accurate at the time of posting. Shortage recovery dates are only estimates. These estimates are based on the distribution information that Genoa has access to.